Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHODH | Q02127 | 6/20 | 0.85 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | PARP1 | P09874 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.58 |
| ▸ | RECQL | P46063 | 1/20 | 0.58 |
| ▸ | BLM | P54132 | 1/20 | 0.58 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | MKNK1 | Q9BUB5 | 3/20 | 0.56 |
| ▸ | MKNK2 | Q9HBH9 | 2/20 | 0.56 |
| ▸ | KMO | O15229 | 1/20 | 0.52 |
| ▸ | IKBKB | O14920 | 2/20 | 0.50 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.50 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.50 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18120862 | 0.92 | DHODH (1.00) | DHODHPOLBCYP3A4PARP1MAPT | |
| SCHEMBL30387022 | 0.92 | DHODH (1.00) | DHODHPOLBCYP3A4PARP1MAPT | |
| SCHEMBL1516770 | 0.91 | DHODH (0.71) | DHODHPOLBCYP3A4PARP1MAPT | |
| SCHEMBL3781228 | 0.88 | DHODH (0.68) | DHODHPOLBCYP3A4PARP1MAPT | |
| SCHEMBL30116316 | 0.86 | DHODH (0.66) | DHODHPOLBCYP3A4PARP1MAPT | |
| SCHEMBL17485202 | 0.86 | DHODH (0.66) | DHODHPOLBCYP3A4PARP1MAPT | |
| SCHEMBL43553 | 0.84 | DHODH (0.70) | DHODHPOLBCYP3A4PARP1MAPT | |
| SCHEMBL27446284 | 0.84 | MKNK1 (0.76) | DHODHPOLBCYP3A4PARP1MAPT | |
| SCHEMBL29788172 | 0.84 | DHODH (0.70) | DHODHPOLBCYP3A4PARP1MAPT | |
| Biphenyl SCHEMBL659450 | 0.83 | MAPT (0.84) | DHODHPOLBCYP3A4PARP1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025068371-A1 | INHIBITORS OF THE PROPROTEIN CONVERTASE FURIN, METHODS OF PRODUCTION THEREOF AND USE | PHILIPPS-UNIVERSITÄT MARBURG (DE) | 2025-04-03 | — | — | WO | disclosed |
| US-20220235087-A1 | MANNOSE-DERIVED ANTAGONISTS OF FIMH USEFUL FOR TREATING DISEASE | FIMBRION THERAPEUTICS, INC. | 2022-07-28 | — | — | US | disclosed |
| US-10559828-B2 | Slurry for lithium ion secondary battery positive electrodes | ZEON CORPORATION (JP) | 2020-02-11 | — | — | US | disclosed |
| CN-108778288-A | It can be used for treating antagonist derived from the mannose of the FimH of disease | 菲姆布里昂医疗公司 | 2018-11-09 | — | — | CN | disclosed |
| EP-2953193-B1 | SLURRY FOR LITHIUM ION SECONDARY BATTERY POSITIVE ELECTRODES | ZEON CORP (JP) | 2018-04-25 | — | — | EP | disclosed |
| US-9748547-B2 | Method for producing electrode/separator laminate, and lithium-ion rechargeable battery | ZEON CORPORATION (JP) | 2017-08-29 | — | — | US | disclosed |
| US-20150357648-A1 | SLURRY FOR LITHIUM ION SECONDARY BATTERY POSITIVE ELECTRODES | ZEON CORPORATION (JP) | 2015-12-10 | — | — | US | disclosed |
| EP-2953193-A1 | SLURRY FOR LITHIUM ION SECONDARY BATTERY POSITIVE ELECTRODES | Zeon Corporation (JP) | 2015-12-09 | — | — | EP | disclosed |
| US-20150311490-A1 | METHOD FOR PRODUCING ELECTRODE/SEPARATOR LAMINATE, AND LITHIUM-ION RECHARGEABLE BATTERY | ZEON CORPORATION (JP) | 2015-10-29 | — | — | US | disclosed |
| US-9159992-B2 | Negative electrode active material for lithium ion secondary battery and lithium ion secondary battery | ZEON CORPORATION (JP) | 2015-10-13 | — | — | US | disclosed |
| EP-2924781-A1 | METHOD FOR PRODUCING ELECTRODE/SEPARATOR LAMINATE, AND LITHIUM-ION RECHARGEABLE BATTERY | Zeon Corporation (JP) | 2015-09-30 | — | — | EP | disclosed |
| EP-2403040-A1 | NEGATIVE ELECTRODE ACTIVE MATERIAL FOR LITHIUM ION SECONDARY BATTERY, AND LITHIUM ION SECONDARY BATTERY | Zeon Corporation (JP) | 2012-01-04 | — | — | EP | disclosed |
| US-3991015-A | High molecular weight copolyamides containing quinazoline dione units | BAYER AKTIENGESELLSCHAFT (DT) | 1976-11-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220235087-A1 | MANNOSE-DERIVED ANTAGONISTS OF FIMH USEFUL FOR TREATING DISEASE | MAN2B2, MAN2A1, MANBA | DHODH 767/4885POLB 3683/4885CYP3A4 4766/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.